Prelude Capital Management, LLC Neurocrine Biosciences Inc Transaction History

Prelude Capital Management, LLC

  • $1.57 Billion
  • Q3 2024

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$92.03 - $107.81 $179,274 - $210,013
1,948 New
1,948 $207,000
Q4 2020

Feb 16, 2021
SELL
$86.91 - $108.33 $133,667 - $166,611
-1,538 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$96.16 - $135.15 $141,643 - $199,075
1,473 Added 2266.15%
1,538 $148,000
Q2 2020

Aug 14, 2020
BUY
$85.09 - $130.36 $5,530 - $8,473
65 New
65 $8,000
Q2 2019

Aug 14, 2019
SELL
$72.24 - $91.27 $35,975 - $45,452
-498 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$69.31 - $91.53 $17,951 - $23,706
259 Added 108.37%
498 $44,000
Q4 2018

Feb 14, 2019
SELL
$68.32 - $124.36 $806,517 - $1.47 Million
-11,805 Reduced 98.02%
239 $17,000
Q3 2018

Nov 14, 2018
SELL
$98.88 - $125.85 $310,582 - $395,294
-3,141 Reduced 20.68%
12,044 $1.48 Million
Q2 2018

Aug 14, 2018
SELL
$75.3 - $105.99 $267,540 - $376,582
-3,553 Reduced 18.96%
15,185 $1.49 Million
Q1 2018

May 15, 2018
BUY
$75.88 - $92.43 $306,024 - $372,770
4,033 Added 27.43%
18,738 $1.55 Million
Q4 2017

Feb 14, 2018
SELL
$58.53 - $77.59 $1.67 Million - $2.22 Million
-28,554 Reduced 66.01%
14,705 $1.14 Million
Q3 2017

Nov 14, 2017
BUY
$47.97 - $61.28 $2.08 Million - $2.65 Million
43,259
43,259 $2.65 Million

Others Institutions Holding NBIX

# of Institutions
624
Shares Held
94.2M
Call Options Held
632K
Put Options Held
621K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $11.8B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email